Provider review
Mochi Health review
An obesity-medicine visit and a dietitian, with the medication price hidden.
The clinical set-up is strong; no low-dose figure can be confirmed publicly before an eligibility request.
Price as published
Mochi Membership $39 first month, then $79/mo (medication billed separately, not membership-included)
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The verdict
Mochi Health puts an obesity-medicine provider and a dietitian on the video visit, which is a stronger clinical starting point than most of this board offers, and it carries several semaglutide formats including oral. The problem for a price-led comparison is that the medication price only appears after an eligibility request, so no low-dose figure can be verified publicly at all — and the membership is required and billed separately from whatever that figure turns out to be. It also operates amid active regulatory and legal scrutiny of compounded GLP-1 across the industry.
The trade-off we would want you to read first
Membership ($79/mo) is required and charged on top of medication
Who it suits, and who it does not
A good fit if
- You want an obesity-medicine clinician and a dietitian on the actual visit
- You want a choice of formats, including oral, to start low with
- You are willing to request eligibility to find out the medication price
Look elsewhere if
- You want to compare total cost before starting an application
- You do not want a membership charged on top of the medication
- You want distance from the current compounded-GLP-1 regulatory picture
How the programme works
Video visit with an obesity-medicine provider and dietitian, then compounded or branded semaglutide in injectable and oral formats. Membership is required and billed separately from medication; the medication price is shown only after an eligibility request, so a low-dose figure cannot be confirmed publicly.
At a glance
- Pricing structure
- Varies by dose, plan or tier
- Consult
- Included in the price
- Compounding
- Network
- Labs
- Optional
- Dietitian support
- Included
Strengths
- Obesity-medicine provider plus dietitian on the video visit
- Several semaglutide formats (injectable and oral) to titrate from a low dose
The other trade-offs
- Medication price is gated behind an eligibility request — no public low-dose figure to verify
- Operates amid active compounded-GLP-1 regulatory and legal scrutiny across the industry
Before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Where this sits on the board
Mochi Health is one of 24 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Funding & disclosures
- A number of links are affiliate or referral links.
- Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
- What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
- Full detail: disclosure page.